The University of Utah's Independent Student Voice

The Daily Utah Chronicle

The University of Utah's Independent Student Voice

The Daily Utah Chronicle

The University of Utah's Independent Student Voice

The Daily Utah Chronicle

Write for Us
Want your voice to be heard? Submit a letter to the editor, send us an op-ed pitch or check out our open positions for the chance to be published by the Daily Utah Chronicle.
@TheChrony
Print Issues

Bayer Lowers Cost of Anthrax Meds

WASHINGTON?Federal officials and Bayer Corp. agreed Wednesday on a lower price for the antibiotic Cipro, the most popular anti-anthrax drug.

The pharmaceutical company will sell the government 100 million pills at 95 cents each, a cost of $95 million. That’s a savings of $82 million from Bayer’s original price of $1.77 a pill, the Department of Health and Human Services said.

“This agreement means that a much larger supply of this important pharmaceutical product will be available if needed,” HHS Secretary Tommy Thompson said in a statement.

“Bayer is fully committed to supplying America in its war on bioterrorism,” said Bayer President Helge Wehmeier.

Bayer holds the patent on Cipro, the antibiotic being prescribed to thousands of postal workers as a precaution to protect them from anthrax infection?as well as to many other people exposed to anthrax-containing letters.

Cipro has been the drug of choice because it is more likely to fight off an unknown strain of the bacterium.

Leave a Comment

Comments (0)

We welcome feedback and dialogue from our community. However, when necessary, The Daily Utah Chronicle reserves the right to remove user comments. Posts may be removed for any of the following reasons: • Comments on a post that do not relate to the subject matter of the story • The use of obscene, threatening, defamatory, or harassing language • Comments advocating illegal activity • Posts violating copyrights or trademarks • Advertisement or promotion of commercial products, services, entities, or individuals • Duplicative comments by the same user. In the case of identical comments only the first submission will be posted. Users who habitually post comments or content that must be removed can be blocked from the comment section.
All The Daily Utah Chronicle Picks Reader Picks Sort: Newest

Your email address will not be published. Required fields are marked *